NovoCure Limited is adapting to the challenges created by the pandemic supporting patients who use its Tumor Treating Fields (TTF) devices to treat brain and lung cancer.
The company markets the Optune TTF device to treat glioblastomas, an aggressive type of brain tumor. It also markets the Optune Lua TTF device to treat malignant pleural mesotheliomas, a...